Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 24, 2023
October 24, 2023
7cf691b8-82e3-41a4-a550-b4285ce9a9bf
Related Documents
Sameness Evaluations in an ANDA — Active Ingredients
Guidance DocumentNovember 8, 2022Center for Drug Evaluation and Research
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.